glp-1 ckd receptor agonists in patients with chronic kidney disease and either overweight or obesity Repurposing Diabetes Therapies in CKD:

Available from: Karagiannis T, Tsapas A, Athanasiadou E, Avgerinos I, Liakos A, Matthews DR et al (2021) GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: a systematic review and meta-analysis

Further electrophysiological study showed that, opposite to the effects on arcuate POMC neurons, GLP-1 hyperpolarizes arcuate NPY neurons indirectly via increased GABA A receptor-mediated neurotransmission of local GABAergic interneurons (Secher et al., 2014

Starting at 1mg for at least two to four weeks remains the recommended approach even for experienced researchers transitioning from other incretin therapies

Moreover, preliminary data from real-world studies show a better metabolic control of T2DM patients with oral semaglutide, which is related to good treatment adherence [98, 99]

The first step to determining if any PCOS treatment is right for you is first understanding how it works and what to expect

I'm going to be following it, and I hope to invite both of you back, perhaps in three, four, five years, so when we have more information, and we can answer some of these questions more definitively